PDGFRB and hepatocellular carcinoma: Moreover, the immunofluorescent assays showed that FAM-labeled ZTRI was greatly accumulated in carcinoma specimen and co-localized well with PDGFRβ in HCC tissues (Fig. 2c), suggesting that ZTRI-based tracer might be developed for detection of PDGFRβ overexpressed in HCC.